Skip to main content
SyntekaBio,Inc. logo

SyntekaBio,Inc. — Investor Relations & Filings

Ticker · 226330 ISIN · KR7226330009 KO Professional, scientific and technical activities
Open in API
Filings indexed 322 across all filing types
Latest filing 2024-05-28 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 226330

About SyntekaBio,Inc.

https://www.syntekabio.com/

SyntekaBio is an AI-driven drug discovery company that utilizes its proprietary supercomputing infrastructure, the AI Bio-Supercom Center, to accelerate pharmaceutical development. The company's core technology, the DeepMatcher® platform, underpins a suite of services for discovering small molecules, antibodies, and neoantigens for personalized cancer vaccines. A key offering is LaunchPad, a factory-like system that continuously generates a stream of 'off-the-shelf' drug candidates for numerous disease targets, aiming to expedite the path to IND-enabling studies. SyntekaBio delivers its solutions through comprehensive discovery partnerships and a modular, cloud-based Software as a Service (SaaS) platform, STB CLOUD, providing researchers with automated tools for drug development and genomics analysis.

Recent filings

Filing Released Lang Actions
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from Syntekabio regarding the adjustment of the conversion price of convertible bonds due to a decline in the stock price. This type of disclosure, which details changes to capital structure instruments like convertible bonds, falls under the category of capital and financing updates.
2024-05-28 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'SyntekaBio' (신테카바이오) covering the period from 2024.01.01 to 2024.03.31. It contains detailed financial information, business operations, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-16 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the granting of stock options (주식매수선택권 부여). It details the number of shares, exercise price, and conditions for employees and related company staff. Since this is a specific regulatory disclosure regarding capital structure and employee compensation that does not fit into the other categories like 'DEF 14A' (which is specifically for executive remuneration reports) or 'SHA' (which is for share issuance), it is classified as a general regulatory filing.
2024-05-14 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. This type of filing is required when an entity or individual acquires a significant stake (typically 5% or more) in a publicly traded company. According to the provided definitions, this falls under 'Major Shareholding Notification' (MRQ), which covers notifications of changes in significant share ownership levels.
2024-05-03 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 100% confidence The document is a formal announcement regarding the 'Result of Securities Issuance' (증권 발행결과) for a private placement of convertible bonds (전환사채). It details the issuance amount, payment date, and references previous board resolutions. This falls under the category of company financing and capital structure updates.
2024-04-26 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정). It details the terms of the bond, including conversion prices, put/call options, and interest rates. This is a regulatory filing required by the Korea Exchange (KRX) for material corporate events. Since it is a specific announcement of a financial instrument issuance rather than a general regulatory notice or a report publication announcement, it falls under the 'Capital/Financing Update' category.
2024-04-01 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.